XML 41 R30.htm IDEA: XBRL DOCUMENT v3.25.2
REVENUE (Tables)
9 Months Ended
Jul. 31, 2025
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenue
The following table presents the company’s total revenue and segment revenue disaggregated by geographical region:
Three Months Ended July 31,
20252024
Life Sciences and Diagnostics MarketsAgilent CrossLabApplied MarketsTotalLife Sciences and Diagnostics MarketsAgilent CrossLabApplied MarketsTotal
(in millions)
Revenue by Region
Americas$316 $274 $93 $683 $268 $267 $91 $626 
Europe201 212 79 492 177 184 71 432 
Asia Pacific153 258 152 563 140 240 140 520 
Total$670 $744 $324 $1,738 $585 $691 $302 $1,578 
Nine Months Ended July 31,
20252024
Life Sciences and Diagnostics MarketsAgilent CrossLabApplied MarketsTotalLife Sciences and Diagnostics MarketsAgilent CrossLabApplied MarketsTotal
(in millions)
Revenue by Region
Americas$953 $805 $272 $2,030 $841 $779 $273 $1,893 
Europe568 594 235 1,397 537 551 228 1,316 
Asia Pacific450 754 456 1,660 431 711 458 1,600 
Total$1,971 $2,153 $963 $5,087 $1,809 $2,041 $959 $4,809 
The following table presents the company’s total revenue disaggregated by end markets and by revenue type:
Three Months EndedNine Months Ended
July 31,July 31,
2025202420252024
(in millions)
Revenue by End Markets
Pharmaceutical and Biopharmaceutical$629 $540 $1,817 $1,647 
Diagnostics and Clinical258 242 753 709 
Academic and Government132 128 404 417 
Chemicals and Advanced Materials399 356 1,147 1,110 
Food157 144 472 440 
Environmental and Forensics163 168 494 486 
Total$1,738 $1,578 $5,087 $4,809 
Revenue by Type
Instrumentation$599 $556 $1,774 $1,734 
Non-instrumentation and other1,139 1,022 3,313 3,075 
Total$1,738 $1,578 $5,087 $4,809 
Contract Liabilities and Changes in Balances
The following table provides information about contract liabilities (deferred revenue) and the changes in the balances during the nine months ended July 31, 2025:
Contract
Liabilities
(in millions)
Ending balance as of October 31, 2024$701 
Net revenue deferred in the period506 
Revenue recognized that was included in the contract liability balance at the beginning of the period(429)
Change in deferrals from customer cash advances, net of revenue recognized13 
Currency translation and other adjustments
Ending balance as of July 31, 2025$800